Surveying how doctors refer people with suspected chronic lymphocytic leukaemia to specialists
Surveys doctors about how they refer chronic lymphocytic leukaemia cases in the West Midlands.
Plain-language title generated from the registry record
Registry title: variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway
Key facts
- Where
- Wolverhampton, United KingdomSee the site
Where in United Kingdom
- The Royal Wolverhampton NHS TrustWolverhampton, United KingdomNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Royal Wolverhampton Hospitals NHS Trust
- Trial code
- NCT07463976
- Record updated
- 15 September 2026
- Original description
This study will use surveys within primary and secondary care to explore referral patterns and healthcare professional (HCP) decision-making and advice for haematological malignancies, identify inequalities, and establish best practice for CLL referrals and specialist support. The project will allow us to understand and 'map' variations in practice across the West Midlands region with regard to referrals for CLL from primary care physicians to haematology services in secondary care.Read full original descriptionShow less
variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway (TITLE CLL)
This study will use surveys within primary and secondary care to explore referral patterns and healthcare professional (HCP) decision-making and advice for haematological malignancies, identify inequalities, and establish best practice for CLL referrals and specialist support. The project will allow us to understand and 'map' variations in practice across the West Midlands region with regard to referrals for CLL from primary care physicians to haematology services in secondary care.
Specific objectives are to:
1. Identify service variations by using surveys to assess differences in CLL service provision across primary and secondary care in the West Midlands 2. Investigate service variations by describing the key characteristics of responding primary care practices (practice size, number of GPs, Integrated Care Board (ICB) locality, deprivation quartile) 3. Propose strategies to improve equity that will enhanced patient outcomes and reduce inequalities in care for CLL patients, aiming to ensure consistent standards for referral and management across different care settings.
Inclusion: Primary Care Provider; Clinical Nurse Specialist.
Exclusion: -.